- Study protocol
- Open Access
Effects of high frequency rTMS of contralesional dorsal premotor cortex in severe subcortical chronic stroke: protocol of a randomized controlled trial with multimodal neuroimaging assessments
BMC Neurology volume 22, Article number: 125 (2022)
Previous studies have revealed that low frequency repeated transcranial magnetic stimulation (rTMS) on the contralesional primary motor cortex (cM1) is less effective in severe stroke patients with poor neural structural reserve than in patients with highly reserved descending motor pathway. This may be attributed to the fact that secondary motor cortex, especially contralesional dorsal premotor cortex (cPMd), might play an important compensatory role in the motor function recovery of severely affected upper extremity. The main purpose of this study is to compare the effectiveness of low frequency rTMS on cM1 and high frequency rTMS on cPMd in subcortical chronic stroke patients with severe hemiplegia. By longitudinal analysis of multimodal neuroimaging data, we hope to elucidate the possible mechanism of brain reorganization following different treatment regimens of rTMS therapy, and to determine the cut-off of stimulation strategy selection based on the degree of neural structural reserve.
The study will be a single-blinded randomized controlled trial involving a total of 60 subcortical chronic stroke patients with severe upper limb motor impairments. All patients will receive 3 weeks of conventional rehabilitation treatment, while they will be divided into three groups and receive different rTMS treatments: cM1 low frequency rTMS (n = 20), cPMd high frequency rTMS (n = 20), and sham stimulation group (n = 20). Clinical functional assessment, multimodal functional MRI (fMRI) scanning, and electrophysiological measurement will be performed before intervention, 3 weeks after intervention, and 4 weeks after the treatment, respectively.
This will be the first study to compare the effects of low-frequency rTMS of cM1 and high-frequency rTMS of cPMd. The outcome of this study will provide a theoretical basis for clarifying the bimodal balance-recovery model of stroke, and provide a strategy for individualized rTMS treatment for stroke in future studies and clinical practice.
Chinese Clinical Trial Registry, ChiCTR1900027399. Registered on 12 Nov 2019, http://www.chictr.org.cn/showproj.aspx?proj=43686.
Hemiplegia is one of the most common functional defects after stroke. Although stroke patients can recover spontaneously, most patients in the chronic phase will still suffer from upper limb dysfunction, especially hand dysfunction. It seriously affects the patients’ abilities of daily living, and imposes a heavy burden on their families and the society .
Transcranial magnetic stimulation (TMS), one of the non-invasive brain stimulation (NIBS) techniques, have been widely used in research and clinical treatment to promote the recovery of motor function in stroke patients due to its safety, noninvasiveness, and painlessness [2, 3]. Repeated TMS (rTMS) is a commonly used stimulation mode developed on the basis of TMS. High frequency rTMS (≥1 Hz) has an excitatory effect on cortex neurons, whereas low frequency rTMS (< 1 Hz) inhibits the activity of cortex neurons [4,5,6]. In recent years, rTMS has shown a great potential in stroke rehabilitation, with many studies reporting that it can improve the motor function of stroke patients with hemiplegia [7,8,9,10]. However, there are also studies reported contrasting results that rTMS does not confer additional benefits in the treatment of hemiplegia [11,12,13,14], with some studies even reporting mild functional regression after rTMS treatment [15, 16]. Moreover, recent reviews on the clinical efficacy of rTMS in the treatment of stroke hemiplegia did not reach a consistent conclusion, especially in patients with severe hemiplegia or at chronic stage [13, 17,18,19,20]. According to the Clinical Application Guidelines for rTMS (2018) , level A evidence supports the use of low-frequency rTMS on contralesional M1, and level B evidence suggests application of high-frequency rTMS on ipsilateral M1 in patients with sub-acute stroke. However, there is no clear recommendation for rTMS stimulation parameters in patients with chronic stroke. Therefore, this calls for high quality evidence that will be used to develop an optimal rTMS protocol for chronic stroke patients with severe hemiplegia.
The interhemispheric inhibition (IHI) model, which is commonly used as the fundamental theory for standardized rTMS treatment, was first proposed by Murase in 2004 , which suggests that the bilateral primary motor cortexes (M1) are connected through the corpus callosum in a balance of competing inhibition in healthy individuals. However, the IHI balance is disturbed after the onset of stroke, thereby leading to over activation of the contralesional hemisphere. Specifically, damage to the affect hemisphere weakens its inhibitory effect on the contralesional hemisphere, ultimately resulting in abnormally increased excitability of cM1. Notably, the over activation of cM1 will in turn inhibit the affect M1, causing a vicious circle. The disrupted balance between bilateral M1 will eventually hinder the motor output and impede the recovery of upper limb motor function in stroke survivors. Ideally, according to the standardized treatment protocol [19, 20], high-frequency rTMS is able to increase the excitability of affected M1, whereas low-frequency rTMS is capable of reducing the excitability of cM1, thereby enabling the disrupted IHI to reach a new equilibrium. However, some studies have found that the standardized rTMS protocol is not suitable for all stroke patients [11, 12]. It is worth noting that patients with severe hemiplegia seem to be less suitable for this standardized rTMS protocol . This has led to some researchers questioning the value of classic IHI imbalance theory in clinical practice. Pino et al.  proposed the bimodal balance-recovery model in stroke recovery, which suggests that determining the mode of recovery to be adopted depends on the degree of damage to the affected hemisphere, namely structural reserve. For example, in patients with less damage (higher structural reserve), the classic IHI imbalance mode will dominate the recovery process, and the increased activation of contralesional hemisphere will not be conducive to motor recovery. In such cases, standardized low frequency rTMS of cM1 can exert therapeutic effects by inhibiting this abnormal excitability. In contrast, for patients with low structure reverse, the recovery process will be dominated by the compensatory mode because the increased motor cortex excitability on the unaffected side will be conducive to rehabilitation. In this case, the standardized low-frequency rTMS protocol might not be effective, and thus applying high-frequency rTMS on cM1 is a better option. Taking these two recovery models together, we believe that if we can identify the cut-off of structural reserve, we might be able to evaluate the real effects (inhibitory or compensatory) of the contralesional hemisphere on motor output. This will aid in selecting the optimum rTMS stimulation strategy on contralesional hemisphere (low frequency or high frequency).
In addition, studies should clarify whether the cM1 should be used as the only target brain area on the contralesional hemisphere in the compensatory model. According to the concept of “segregation” in classic brain research, different regions of the cerebral cortex have relatively different functions and each region is responsible for a specific functional task. In fact, even for the simplest functional tasks such as reaching, a wide range of different brain regions need to interact and coordinate to form a network to complete these tasks, a process referred to as “functional integration” . Therefore, to complete a motor task, secondary motor areas like premotor cortex (PMC), supplementary motor area (SMA), cingulate motor area (CMA), and other moto-related brain regions may also be involved along with the primary motor cortex. However, most rTMS studies in stroke rehabilitation have only focused on M1. When the corticospinal tract (CST) is severely damaged, it is possible that the brain reorganization pattern may not only be associated with M1; the secondary motor cortex closely linked to M1 may also be involved .
Against this background and based on our previous studies [24,25,26,27,28,29,30], we propose that PMC might play a key role beyond M1. This can be attributed to several reasons. First, homologous regions of bilateral hemispheres are connected through the corpus callosum, and the connections between bilateral PMC form the largest proportion of white matter fibers of the corpus callosum, rather than between bilateral M1 . This provides the structural basis for the existence of IHI in PMC as it is in M1. Thus, the interaction between bilateral PMC in stroke recovery is worth more attention. Second, PMC is composed of the dorsal part (PMd) and the ventral part (PMv). Previous studies revealed that PMd was involved in the coordination and control of the complex movements of hands . Uncrossed corticospinal ventral tracts originating ipsilateral from PMd (approximately 10–20% of CST) were also found in animal studies . Moreover, PMd is associated with the reticulospinal tract and the red nucleus spinal tract emanating from the brain stem, mainly inculcating the ipsilateral proximal limb . This implies that cPMd may play a compensatory role in promoting motor functional recovery through the ipsilateral inculcating pathway. Third, we have previously conducted a resting-state fMRI study in chronic stroke patients, and found that the betweenness centrality (BC) of cPMd in the stroke group was significantly lower than that in the healthy group. In addition, the BC value of cPMd was significantly positively correlated with the score of the upper limb motor function on the ipsilateral side. These results suggest that the more compensatory effects cPMd provide, the better the motor prognosis for severe stroke patients . Based on the above three points, we hypothesized that cPMd may play a role as a potential target brain area for promoting brain reorganization in rTMS therapy.
Currently, only sporadic reports of high frequency rTMS on cPMd in stroke treatment exist. Johansen-Berg et al.  stimulated the cPMd of stroke patients with mono-pulse TMS, and found a negative correlation between the stimulus intensity and the lateral index of PMd activation in task-based fMRI, as well as a positive correlation to the hemiplegic hand motor function score. This suggests that TMS is capable of activating excitatory effects on cPMd, and facilitating the motor recovery of upper limb and hand in stroke patients. In addition, Bestmann et al.  found that stroke patients with more severe dysfunction demonstrated more activation in cPMd and the posterior part of M1 (BA4p) on the affected side when a single high-frequency TMS stimulated cPMd. This suggests that exciting cPMd with single high-frequency TMS may cause the activation points of the affected hand projection cortex to shift backward, thereby promoting functional recovery. A recent randomized sham-controlled crossover study published in 2017 compared the effects of single-pulse low-frequency TMS on M1, high-frequency TMS on cPMd, and sham stimulation in 15 stroke patients. The results showed that treatment using single-pulse high-frequency TMS on cPMd resulted in a greater improvement than using single-pulse low-frequency TMS on cM1 in severely affected patients . However, these evidences were all based on cross-sectional studies, and longitudinal treatment studies on single-pulse high-frequency rTMS of cPMd are still lacking. Moreover, most of the existing studies utilized single-mode fMRI analysis, which could not thoroughly demonstrate the brain network reorganization patterns of rTMS in promoting functional recovery in stroke patients. Therefore, future studies should use multimodal fMRI (structural, functional, and effective network) to elucidate the mechanisms of this new protocol of rTMS in stroke rehabilitation from multiple perspectives of neural repair and remodeling.
Aims and hypotheses
This study will conduct a longitudinal, single-blinded, randomized controlled trial to verify the clinical effects of different protocols of rTMS therapy on functional recovery of chronic subcortical stroke patients with severe hemiplegic upper limb. To the best of our knowledge, this is the first study to compare the effects of low-frequency rTMS on cM1 and high-frequency rTMS on cPMd. We expect that the findings will provide vital information about the optimal rTMS strategy. Multimodal fMRI scanning and electrophysiological measurements will be performed longitudinally to elucidate the underlying neural mechanism of brain reorganization after different parameters of rTMS therapy. We hypothesize that high-frequency rTMS on cPMd might be the optimal protocol for motor functional recovery in chronic subcortical stroke patients with severe hemiplegia. This clinical effect may be attributed to the specific remodeling patterns of structural, functional, or effective connectivity of homologous or allogeneic cortexes within or between hemispheres through multimodal neural imaging analysis. Furthermore, joint analysis of the clinical and neuroimaging results might identify the cut-off of structural reserve that determines the application of high/low frequency rTMS on contralesional hemisphere to achieve maximum functional recovery of the paretic upper limb.
The study will be conducted at Huashan Hospital, Fudan University and The Third Rehabilitation Hospital, Shanghai. Signed informed consent will be obtained from all participants prior to the study. Briefly, chronic (onset time > 3 months) subcortical stroke patients with severe hemiplegia will receive conventional rehabilitation treatment and three different protocols of rTMS intervention: low-frequency rTMS of cM1, high-frequency rTMS of cPMd, and sham stimulation. Next, multimodal fMRI scanning (DTI, rs-fMRI, and tb-fMRI), functional assessments, and electrophysiological assessments will be performed before intervention (T0), 3 weeks after intervention (T1), and 4 weeks after the end of treatment (T2), respectively. Figure 1 shows the flow-diagram of the study design.
Patients will be recruited from Huashan Hospital Fudan University and the Third Rehabilitation Hospital of Shanghai. The legal rights and interests of them will not be violated during the study. For the intervention, subjects’ privacy will be fully respected and their personal information will be kept strictly confidential.
Inclusion and exclusion criteria
A total of 60 eligible patients will be recruited from Huashan Hospital, Fudan University. The inclusion and exclusion criteria are listed in Table 1.
Randomization and grouping
The 60 eligible stroke patients will be randomly assigned to three groups with 20 patients in each group: low-frequency rTMS of cM1 (cM1-LF) group, high-frequency rTMS of cPMd (cPMd-HF) group, and sham-stimulation control (CON) group. The random sequence will be created using STATA 12.0 software (StataCorp, Texas, USA) by a professional third-party statistician from Fudan University. The randomization list will only be known by this research coordinator and will be concealed from other study personnel. However, the research coordinator will not participate in recruitment, subsequent intervention and assessment, and final data analysis. In addition, 20 healthy people will be recruited into the healthy control (HC) group. The HC group will be matched with stroke groups in terms of age, gender, and education.
This trial will utilize a randomized, patient-and assessor-blinded, parallel-group design. The patients, assessors, and statisticians will not be aware of the group assignment. They will only be informed of the group’s identification (group A, group B, and group C) but not be aware of which group is the cM1-LF, cPMd-HF, and CON group. Physicians will be divided into two groups: one group responsible for screening and assessing patients, and the other group responsible for applying rTMS intervention. Notably, the former will be blinded to group assignment, but the later cannot be blinded since applying rTMS over different stimulation sites implies the assignment.
Conventional rehabilitation intervention and rTMS intervention
In addition to the routine pharmacotherapy, the three groups of patients will undergo 40 min of conventional rehabilitation, including physical therapy of upper limb function (PT) and daily living ability training (OT), once each day, 5 days a week, for a total of 3 weeks. Moreover, all stroke patients will receive the same dose of other routine rehabilitation treatments such as biofeedback electrical stimulation, acupuncture, and massage for 3 weeks.
For rTMS intervention, ① patients in the cM1-LF group will be treated as follows: 100 sessions of 1 Hz rTMS at 90% resting motor threshold (RMT) to cM1 (at the optimal stimulus point with the largest and most consistent MEP), 10 pulses per session with a 2-s interval between sessions, totaling 1000 pulses (20 min); ② patients in the cPMd-HF group will be treated as follows: 20 sessions of 5 Hz rTMS at 90% RMT to cPMd (2 cm in front and 1 cm in the inner side of the optimal stimulus point of M1), 50 pulses per session with a 50-s interval between sessions, totaling 1000 pulses (20 min) (Fig. 2); and ③ patients in the CON group will be treated with the same parameters as cM1-LF group (including location, stimulation frequency, and time), however, the coil will be placed perpendicular to the surface of the skull to emit the same stimulating sound as the cM1-LF group but without effective stimulation. All patients in the three groups will receive rTMS intervention once a day for 5 days a week, for 3 weeks.
If any patients experience headaches, nausea, or changes in their condition throughout the interventions, we will terminate the interventions and provide timely medical assistance. Adverse events will also be reported to the ETHICS committee.
All patients will receive clinical function assessment, electrophysiological measurement, and multimodal fMRI scanning at all time points. Healthy subjects will only receive fMRI scanning scan at T0. The outcome measure timing is listed in Table 2.
Clinical function assessment and electrophysiological assessment
Clinical function assessment and electrophysiological measurement will be performed at T0, T1, and T2 in Huashan Hospital, Fudan University. The level of motor function will be assessed based on the Brunnstrom stage. Manual muscle test (MMT) and modified Ashworth scale (MAS) will be used to assess muscle strength and muscle tone of the limbs, respectively, whereas the national Institutes of Health Stroke Scale (NIHSS) will be used to assess the severity of neurological deficits in stroke. In addition, Fugl-Meyer Upper Limb Motor Function Rating Scale (FM-UL), Action Research Arm Test Scale (ARAT) and Wolf Motor Function Test Scale (WMFT) will be used to assess the motor function of the affected arm and hand. Activities of daily Living (ADL) will be evaluated using the Modified Barthel Index (MBI).
For electrophysiological evaluation, single-pulse TMS (YRD CCY-4, Yi Ruide Company, Wuhan, China) will be used to assess bilateral hemispherical MEP using a 8-figured coil with an external wing of 7 cm. We will first determine the optimal stimulus point, the location on the scalp with the largest and most consistent MEP in the contralateral Abductor Pollicis Brevis (APB), from which the subsequent neurophysiological assessments will be performed. The resting motor threshold (RMT), which is the minimal stimulus intensity required to evoke MEPs with amplitudes of ≥50 μV in at least five out of 10 consecutive trails, will be determined as the amplitude reference. MEP amplitude and latency, i.e., the peak to peak amplitude and the time period between stimulation onset and start of the largest MEP, will be measured and recorded. In instances where MEP will be recorded in the affected-side APB, it will be denoted as MEP (+), and if multiple measurements fail to yield a MEP, it will be denoted as MEP (−).
The multimodal fMRI scanning will be performed for patients at T0, T1, and T2, and at T0 for healthy subjects using a Siemens Trio 3 Tesla MRI scanner (Siemens, Erlangen, Germany) in Shanghai Key Magnetic Resonance Laboratory of East China Normal University.
① Motor tasks
A block design will be adopted for the task-based fMRI scanning. In each run, there will be five blocks in baseline and five blocks in task state, and each block will last 30 s (as shown in Fig. 3). In addition, each run will be preceded by a 6 s empty scan, thus, the total time for each run will be 5 min and 6 s.
In each task state block, the experimenter will make a passive clench motion of fingers on the subject after receiving the “close” command. Next, the experimenter will make a passive stretching motion of fingers on the subject upon hearing “open”, with a frequency of about 1 Hz and the maximum range. Each subject will be asked to complete two groups of exercise tasks: left-hand passive clenching and right-hand passive clenching. Notably, each subject will receive relevant stimulus task training and guidance prior to fMRI.
② Data acquisition
The multimodal scans will be performed in accordance with the parameters listed in Table 3. TE is the time of echo, TR is the time of repetition, MPRAGE is magnetization prepared rapid acquisition with gradient echo sequence, TSE is turbo spin echo sequence, and SS-EPI is single shot gradient echo imaging sequence. In addition, for DTI, the diffusion weighted images will be acquired along 10 diffusion directions with b = 0 and 64 different diffusion directions with b = 1000 s/mm2.
Data processing and analysis
MRI data will be preprocessed using SPM 8 software. The data of patients with left hemisphere lesions will be flipped along the midsagittal plane to ensure that all the patients have “virtual” right hemisphere lesions. SPM 8 will also be used for BLOD fMRI data preprocessing. Slicing timing, realignment, normalization, and smoothing will be performed on the BLOD fMRI data. Next, the data with translation parameter greater than ±2.5 mm or rotation parameter greater than ±2.5 degrees will be removed. Finally, the diffusion toolkit software (http://www.trackvis.org/dtk/) will be used to pre-process the DTI data.
A total of 90 network nodes will be defined according to Anatomical Automatic Labeling (AAL) atlas. Pearson correlation analyses will then be performed on the preprocessed RS fMRI data, which will result in one 90 × 90 correlation matrix representing the functional connection between each two network nodes. A threshold will be used to binarize the matrix, and all correlation coefficients greater than the threshold will be assigned 1, otherwise 0. Topology attributes, including global network efficiency (Eg), local network efficiency (El), network betweenness, and clustering coefficient will be calculated for each patient based on the correlation matrix.
For each patient, the preprocessed task fMRI data will be used to construct a general linear model (GLM) according to the experimental design, with a regression on the head-motion parameters.
The bilateral posterior limb of internal capsule (PLIC), bilateral cerebral peduncle, and corpus callosum of each patient will be delineated manually by two radiologists. For each patient, the common part of the results recorded by the two radiologists will be adopted as the regions of interest (ROIs). The mean fractional anisotropy (FA) will be calculated with all the ROIs for each hemisphere. Notably, FA asymmetery index (FA AI) is defined by the following formula:
where FAc is the FA of the contralesional hemisphere and FAa is the FA of the affected hemisphere. FA AI can be used to quantitatively evaluate the structural integrity of CST and corpus callosum.
Sample size calculation
The sample size for this study was calculated using SPSS 21 software based on a previous study . The mean score of FM-UL assessment in patients who received low-frequency rTMS treatment was 30 at baseline and increased to 43 after intervention, with a common standard deviation of 17. Furthermore, we assumed that the study would have a dropout of 30%, and thus the final target sample size was 60 participants, with 20 assigned to each group when setting a power of 80% and a significance level of 0.05.
All statistical analyses will be performed using SPSS software (SPSS 25.0, SPSS Inc., Chicago, Illinois). The intention-to-treat principle will be used for the analysis of functional and electrophysiological data. One-way analysis of variance (ANOVA) will be used to compare the demographic characteristics and baseline assessment (T0) of all outcomes among groups. To compare the treatment effects of different rTMS protocol, a two-way mixed design ANOVA with between-subject factor “Group” and within-subject factor “Time” will be performed for the clinical and electrophysiological changes. Moreover, Bonferroni correction will be employed for post hoc multiple comparisons. P < 0.05 will be considered statistically significant for all analyses.
For rs-fMRI and DTI data, a two-way mixed design ANOVA will be performed, with between-subject factor “Group” and within-subject factor “Time” on the data generated in the data processing step, including Eg, El, network betweenness, clustering coefficient, and FA AI. For tb-fMRI data, a whole brain paired T-test will be performed between the task state blocks and baseline blocks in the FC group, and the voxels whose t value is higher than the threshold will be regarded as the activated brain region. For cM1-LF, cPMd-HF, and CON groups, a two-way mixed design ANOVA, with between-subject factor “Group” and within-subject factor “Time” will be performed within the former activated brain region. The most significant point of “Group” × “Time” effect in the activated brain region will be used as the center to construct spherical balls with a radius of 6 mm, and the spherical balls will be regarded as the ROIs. Finally, to obtain the effective connectivity of each patient at different time points, the average time series of all voxels in each ROI will be subjected to dynamic causal model (DCM) analysis.
Pearson correlation analysis will be performed between electrophysiological parameters, MRI parameters, and clinical function scores in cM1 LF group and cPMd HF group. The statistical threshold will be set to p < 0.05.
Huashan Hospital will monitor the following aspects of the trial regularly and strictly: the work division and training for the research staff, file management, informed consent, protocol compliance, subject recruitment, filling in the CRF, intervention, quality assured system, statistical analysis, and data management.
Several studies conducted in recent years have confirmed that rTMS can effectively improve the motor function of stroke patients with hemiplegia [7,8,9,10]. However, negative results have also been reported, with some studies even observing functional regression in some patients [11,12,13,14,15,16]. These evidences suggest that the standardized rTMS protocol based on the IHI imbalance theory between bilateral M1 has its limitation in clinical practice [19, 20]. In chronic stroke patients with severe motor impairments, extensive damage to affected pathway of motor output hinders the effects of affected M1 in motor recovery, thereby rendering classic rTMS protocol ineffective . Thus, this study will focus on cPMd based on a more recent “bimodal balance-recovery model” . Evidence suggests that inhibition of cPMd directly impairs movement of the paretic extremity in severe patients , and the betweenness centrality of cPMd is significantly positively correlated with the motor score . Therefore, we hypothesized that cPMd is more likely to be the key factor for functional recovery of severely affected patients. This hypothesis will be verified by conducting a randomized controlled trial, which will directly compare the effects of low-frequency rTMS on cM1, high-frequency rTMS on cPMd, and sham-stimulation. It is expected that the findings of the study will facilitate development of a new protocol of rTMS therapy for treating severely affected stroke patients.
In addition to potential clinical influence, the study will elucidate the underlying mechanism of brain plasticity though longitudinal analysis of multimodal fMRI data scanned before and after the intervention, and during the follow up. It is worth noting that rest-state fMRI will provide information about the changes of brain networks, task-based fMRI will display the brain activation model of specific task instantly, and DTI will provide insights into the remodeling of motor pathway. Collectively, the results will help us to further understand the neural effects of different protocols of rTMS therapy in stroke rehabilitation. Furthermore, the joint analysis of neuroimaging data and functional changes will indicate the cut-off that separates mildly from severely affected patients, ultimately guiding application of tailored stimulation parameters for rTMS (i.e. low-frequency rTMS on cM1 or high-frequency rTMS on cPMd). In conclusion, this study will provide a theoretical basis for clarifying the bimodal balance-recovery model of stroke, provide biological markers for predicting the functional prognosis in chronic stroke patients after rTMS therapy, and provide a strategy for individualized rTMS treatment for stroke in future studies and clinical practice.
This trial was registered on 12 November 2019. Patient recruitment began on 1 January 2020 and will continue until 31 December 2023. Recruitment was not completed at the time of submission.
Availability of data and materials
The metadata and protocol will be submitted to the clinical trial center of Huashan Hospital before June 30,2024. And the calculated results will be able to be downloaded at http://www.chictr.org.cn/showproj.aspx?proj=43686.
Transcranial magnetic stimulation
Primary motor cortex
Contralesional dorsal PMC
Non-invasive brain stimulation
Supplementary motor area
Cingulate motor area
Conventional rehabilitation training
Manual muscle test
National Institutes of Health Stroke Scale
Modified Ashworth scale
Fugl-Meyer Upper Limb Motor Function Rating Scale
Action Research Arm Test Scale
Wolf Motor Function Test Scale
Activities of daily Living
Modified Barthel Index
Motor evoked potential
Abductor Pollicis Brevis
Resting motor threshold
Anatomical Automatic Labeling
General linear model
Posterior limb of internal capsule
Regions of interest
Dynamic causal model
Dobkin BH. Rehabilitation after stroke [J]. N Engl J Med. 2005;352:1677–84.
Le Q, Qu Y, Tao Y, Zhu S. Effects of repetitive transcranial magnetic stimulation on hand function recovery and excitability of the motor cortex after stroke: a meta analysis [J]. Am J Phys Med Rehabil. 2014;93(5):422–30.
Smith MC, Stinear CM. Transcranial magnetic stimulation (TMS) in stroke: ready for clinical practice [J]? J Clin Neurosci. 2016;31:10–4.
Brion JP, Demeurisse G, Capon A. Evidence of cortical reorganization in hemiparetic patients [J]. Stroke. 1989;20(8):1079–84.
Cao Y, D'Olhaberriague L, Vikingstad EM, Levine SR, Welch KM. Pilot study of functional MRI to assess cerebral activation of motor function after poststroke hemiparesis [J]. Stroke. 1998;29(1):112–22.
Hummel FC, Cohen LG. Non-invasive brain stimulation: a new strategy to improve neurorehabilitation after stroke [J]. Lancet Neurol. 2006;5(8):708–12.
Ackerley SJ, Byblow WD, Barber PA, MacDonald H, McIntyre-Robinson A, Stinear CM. Primed physical therapy enhances recovery of upper limb function in chronic stroke patients [J]. Neurorehabil Neural Repair. 2016;30(4):339–48.
Kim DH, Shin JC, Jung S, Jung TM, Kim DY. Effects of intermittent theta burst stimulation on spasticity after stroke [J]. Neuroreport. 2015;26(10):561–6.
Huang GL, Tang XL, Huang Y. Effects of 1Hz low frequency repetitive transcranial magnetic stimulation on upper limb spasm and motor function in hemiplegia after stroke: a meta-analysis [J]. Chin J Rehabil Med. 2018;33(6):701–9.
Zhao XL, Liu TL, Zhou YX, Zhang LX. The effect of repetitive transcranial magnetic stimulation on dyskinesia in stroke patients [J]. Chin J Rehabil Med. 2018;33(7):800–5.
Barros Galvão SC, Costa B, dos Santos R, Borba dos Santos P, Cabral ME, Monte-Silva K. Efficacy of coupling repetitive transcranial magnetic stimulation and physical therapy to reduce upper-limb spasticity in patients with stroke: a randomized controlled trial [J]. Arch Phys Med Rehabil. 2014;95(2):222–9.
Seniów J, Bilik M, Leśniak M, Waldowski K, Iwański S, Członkowska A. Transcranial magnetic stimulation combined with physiotherapy in rehabilitation of poststroke hemiparesis: a randomized, doubleblind, placebo-controlled study [J]. Neurorehabi Neural Repair. 2012;26(9):1072–9.
Hsu WY, Cheng CH, Liao KK, et al. Effects of repetitive Transcranial magnetic stimulation on motor functions in patients with stroke a Meta-analysis[J]. Stroke. 2012;43(7):1849.
Harvey RL, Dylan E, Kari D, et al. Randomized sham-controlled trial of navigated repetitive Transcranial magnetic stimulation for motor recovery in stroke: the NICHE trial[J]. Stroke. 2018;49(9):2138–46.
Ackerley SJ, Stinear CM, Barber PA, Byblow WD. Combining theta burst stimulation with training after subcortical stroke [J]. Stroke. 2010;41(7):1568–72.
Ameli M, Grefkes C, Kemper F, Riegg FP, Rehme AK, Karbe H, et al. Differential effects of high-frequency repetitive transcranial magnetic stimulation over ipsilesional primary motor cortex in cortical and subcortical middle cerebral artery stroke [J]. Ann Neurol. 2009;66(3):298–309.
Hao Z, Wang D, Zeng Y, Liu M. Repetitive transcranial magnetic stimulation for improving function after stroke [J]. Cochrane Database Syst Rev. 2013;31(5):CD008862.
Adeyemo BO, Simis M, Macea DD, Fregni F. Systematic review of parameters of stimulation, clinical trial design characteristics, and motor outcomes in non-invasive brain stimulation in stroke [J]. Front Psychiatry. 2012;3:1–27.
Kubis N. Non-invasive brain stimulation to enhance post-stroke recovery [J]. Front Neural Circuits. 2016;10:56–65.
Dionísio A, Duarte IC, Patrício M, Castelo-Branco M. The use of repetitive Transcranial magnetic stimulation for stroke rehabilitation: a systematic review [J]. J Stroke Cerebrovasc Dis. 2018;27(1):1–31.
Lefaucheur JP, Aleman A, Baeken C, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018) [published correction appears in Clin Neurophysiol. 2020 May;131(5):1168-1169]. Clin Neurophysiol. 2020;131(2):474–528.
Murase N, Duque J, Mazzocchio R, Cohen LG. Influence of interhemispheric interactions on motor function in chronic stroke [J]. Ann Neurol. 2004;55(3):400–9.
Di Pino G, Pellegrino G, Assenza G, Capone F, Ferreri F, Formica D, et al. Modulation of brain plasticity in stroke: a novel model for neurorehabilitation [J]. Nat Rev Neurol. 2014;10(10):597–608.
Rubinov M, Sporns O. Complex network measures of brain connectivity: uses and interpretations [J]. Neuroimage. 2010;52(3):1059–69.
Zeiler SR, Gibson EM, Hoesch RE, Li MY, Worley PF, O’Brien RJ, et al. Medial premotor cortex shows a reduction in inhibitory markers and mediates recovery in a mouse model of focal stroke [J]. Stroke. 2013;44(2):483–9.
Fang PC, Stepniewska I, Kaas JH. Corpus callosum connections of subdivisions of motor and premotor cortex, and frontal eye field in a prosimian primate, Otolemur garnetti. J Comp Neurol. 2008;508(4):565–78.
Kurata K. Hierarchical Organization Within the Ventral Premotor Cortex of the Macaque Monkey. Neuroscience. 2018;382:127–43.
Kuypers HGJM. Anatomy of the descending pathways. In: Brookhart JM, Mountcastle VB, editors. Handbook of physiology - the nervous system II. Bethesda: American Physiological Society; 1981. p. 597–666.
Zaaimi B, Edgley SA, Soteropoulos DS, Baker SN. Changes in descending motor pathway connectivity after corticospinal tract lesion in macaque monkey [J]. Brain. 2012;135(7):2277–89.
Zhao Z, Wu J, Fan M, Yin D, Tang C, Gong J, et al. Altered intra- and inter-network functional coupling of resting-state networks associated with motor dysfunction in stroke [J]. Hum Brain Mapp. 2018;39(8):3388–97.
Johansen-Berg H, Rushworth MF, Bogdanovic MD, Kischka U, Wimalaratna S, Matthews PM. The role of ipsilateral premotor cortex in hand movement after stroke [J]. Proc Natl Acad Sci U S A. 2002;99:14518–23.
Bestmann S, Swayne O, Blankenburg F, Ruff CC, Teo J, Weiskopf N, et al. The role of contralesional dorsal premotor cortex after stroke as studied with concurrent TMS-fMRI [J]. J Neurosci. 2010;30(36):11926–37.
Sankarasubramanian V, Machado AG, Conforto AB, Potter-Baker KA, Cunningham DA, Varnerin NM, et al. Inhibition versus facilitation of contralesional motor cortices in stroke: deriving a model to tailor brain stimulation [J]. Clin Neurophysiol. 2017;128(6):892–902.
Du J, Yang F, Hu J, et al. Effects of high- and low-frequency repetitive transcranial magnetic stimulation on motor recovery in early stroke patients: Evidence from a randomized controlled trial with clinical, neurophysiological and functional imaging assessments. Neuroimage Clin. 2019;21:101620.
Zhao Z, Wang X, Fan M, Yin D, Sun L, Jia J, et al. Altered effective connectivity of the primary motor cortex in stroke: a resting-state fMRI study with granger causality analysis [J]. PLoS One. 2016;11(11):e0166210.
Yin D, Yan X, Fan M, Hu Y, Men W, Sun L, et al. Secondary degeneration detected by combining voxel-based morphometry and tract-based spatial statistics in subcortical strokes with different outcomes in hand function [J]. AJNR Am J Neuroradiol. 2013;34(7):1341–7.
Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200–7.
Zheng X, Sun L, Yin D, Jia J, Zhao Z, Jiang Y, et al. The plasticity of intrinsic functional connectivity patterns associated with rehabilitation intervention in chronic stroke patients [J]. Neuroradiology. 2016;58(4):417–27.
Sun L, Yin D, Zhu Y, Fan M, Zang L, Wu Y, et al. Cortical reorganization after motor imagery training in chronic stroke patients with severe motor impairment: a longitudinal fmri study [J]. Neuroradiology. 2013;55(7):913–25.
Yin D, Song F, Xu D, Peterson BS, Sun L, Men W, et al. Patterns in cortical connectivity for determining outcomes in hand function after subcortical stroke [J]. PLoS One. 2012;7(12):e52727.
Zhao Z, Tang C, Yin D, Wu J, Gong J, Sun L, et al. Frequency-specific alterations of regional homogeneity in subcortical stroke patients with different outcomes in hand function [J]. Hum Brain Mapp. 2018;39(11):4373–84.
Yin D, Song F, Xu D, Sun L, Men W, Zang L, et al. Altered topological properties of the cortical motor-related network in patients with subcortical stroke revealed by graph theoretical analysis [J]. Hum Brain Mapp. 2014;35(7):3343–59.
Yin D, Luo Y, Song F, Xu D, Peterson BS, Sun L, et al. Functional reorganization associated with outcome in hand function after stroke revealed by regional homogeneity [J]. Neuroradiology. 2013;55(6):761–70.
Sun L, Wu Y, Yin D, Fan M, Zang L, Hu Y, et al. The effects of motor imagery training on upper-extremity functional reorganization in stroke patients: a fMRI study [J]. Chin J Rehabil Med. 2015;30(12):1217 -1222, 1242.
Shao F, Yin D, Jia J, Zhao Z, Wang X, Zheng X, et al. The effect of subcortical stroke on motor imagery-related cortex functional connectivity [J]. Chin J Rehabil Med. 2016;31(2):133–9.
The authors thank all those who participated in the trial.
The study will eventually be published in a peer-reviewed journal, and the findings will be presented at conferences, rehabilitation forums and to the general public.
This work was supported by the National Natural Science Foundation of China (No. 81974356). Additional support for participant recruitment and regulatory affairs was provided by the National Natural Science Foundation of China (No. 81401859, 81471651 and 82102665); the Shanghai Sailing Program (No. 21YF1404600); and the National Key R&D Program of China (No. 2020YFC2004200). The funders had no role in study design, data collection and analysis, or preparation of the manuscript.
Ethics approval and consent to participate
The study proposal has been approved by the Ethics Committee of Huashan Hospital affiliated to Fudan University (2019–504). All eligible participants will sign informed consent forms on their willingness to participate in the study. Any modifications to the protocol will be agreed to by the review board. The results and data obtained in this study will be completely kept in the hospital, thereby allowing the investigator, the representative of the sponsor of this study, and the ethics committee to access all trial records.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Li, J., Wang, H., Yuan, Y. et al. Effects of high frequency rTMS of contralesional dorsal premotor cortex in severe subcortical chronic stroke: protocol of a randomized controlled trial with multimodal neuroimaging assessments. BMC Neurol 22, 125 (2022). https://doi.org/10.1186/s12883-022-02629-x
- Transcranial magnetic stimulation
- Dorsal premotor cortex
- Functional MRI